Neuraxis, Inc. Files 8-K Current Report

Ticker: NRXS · Form: 8-K · Filed: Oct 24, 2025 · CIK: 1933567

Neuraxis, INC 8-K Filing Summary
FieldDetail
CompanyNeuraxis, INC (NRXS)
Form Type8-K
Filed DateOct 24, 2025
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.001, $3,300,000, $6,270,000
Sentimentneutral

Sentiment: neutral

Topics: 8-k, filing

TL;DR

Neuraxis filed an 8-K on 10/24 for an event on 10/23. Check for details.

AI Summary

Neuraxis, Inc. filed an 8-K on October 24, 2025, reporting an event on October 23, 2025. The filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934. The company is incorporated in Delaware and its principal executive offices are located in Carmel, Indiana.

Why It Matters

This 8-K filing indicates a material event has occurred for Neuraxis, Inc., requiring public disclosure. Investors should review the filing for details on the nature of the event.

Risk Assessment

Risk Level: low — This filing is a standard 8-K current report and does not inherently indicate negative news or significant risk.

Key Players & Entities

FAQ

What is the specific event being reported in this 8-K filing?

The filing does not specify the exact event, only that it is a 'Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' and lists 'Other Events' and 'Financial Statements and Exhibits' as item information.

When was the earliest event reported in this filing?

The earliest event reported was on October 23, 2025.

When was this 8-K form filed with the SEC?

This 8-K form was filed on October 24, 2025.

What is Neuraxis, Inc.'s state of incorporation?

Neuraxis, Inc. is incorporated in Delaware.

Where are Neuraxis, Inc.'s principal executive offices located?

Neuraxis, Inc.'s principal executive offices are located at 11611 N. Meridian St, Suite 330, Carmel, IN 46032.

Filing Stats: 862 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2025-10-24 08:22:36

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 24, 2025 NEURAXIS, INC. By: /s/ Brian Carrico Name: Brian Carrico Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing